BioNexus Gene Lab Corp.

NASDAQ: BGLC · Real-Time Price · USD
5.27
-0.09 (-1.68%)
At close: Aug 15, 2025, 3:49 PM

BioNexus Gene Lab Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.14M 2.52M 2.63M 1.97M 2.38M 2.27M 2.55M 2.57M 2.38M 2.84M 2.58M 2.49M 3.03M 3.25M 3.58M 3.09M 3.45M
Cost of Revenue
1.79M 2.21M 2.3M 1.69M 2.04M 2.01M 2.2M 2.23M 2.01M 2.5M 2.28M 2.24M 2.7M 2.79M 2.89M 2.62M 2.87M
Gross Profit
343.49K 309.23K 326.54K 288.72K 344.89K 266.56K 354.33K 339.71K 368.9K 339.23K 299.5K 243.32K 333.54K 455.55K 688.1K 467.61K 582.57K
Operating Income
-618.42K -416.22K -1.34M 259.17K -280.88K 256.71K -2.53M -272.2K -50.63K -122.69K -65.22K -137.96K 34.69K 201.06K 372.64K 139.99K 342.1K
Interest Income
23.57K 147.64K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-623.33K -422.03K -1.34M 254.69K -83.69K 252.53K -2.53M -275.24K -53.08K -127.45K -67.29K -140.28K 31.36K 197.08K 370.49K 136.54K 338.74K
Net Income
-623.33K -348.32K -1.35M 199.1K -103.76K 307.42K -2.61M -259.25K -69.07K -156.97K -77.4K -138.66K 17.07K 89.24K 295.32K 28.26K 338.74K
Selling & General & Admin
-148.82K 469.4K 2.13M 759.66K 625.77K -15.91K 3.08M 807.08K 536.87K 487.86K 418.82K 434.12K 345.24K 161.21K 362.31K 378.05K 302.85K
Research & Development
12.14K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
n/a 256.05K -465.53K -730.11K n/a 479.97K -199.28K n/a -117.34K -25.94K -54.11K -52.84K -46.39K 159.66K -46.85K -50.43K -62.39K
Operating Expenses
-136.68K 725.45K 1.66M 29.55K 625.77K 9.85K 2.88M 611.91K 419.53K 461.92K 364.71K 381.29K 298.85K 254.49K 315.46K 327.62K 240.46K
Interest Expense
4.91K 5.81K 6.19K 4.48K 4.66K 4.18K 4.26K 3.04K 2.44K 4.76K 2.07K 2.32K 3.33K 3.99K 2.15K 3.45K 3.36K
Selling & Marketing Expenses
-540.7K 2.03M n/a n/a -20.14K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
1.66M 2.94M 3.97M 2.45M 2.66M 2.02M 5.08M 2.84M 2.43M 2.96M 2.64M 2.62M 2.99M 3.04M 3.2M 2.95M 3.11M
Income Tax Expense
n/a -73.71K 1.55K 55.58K 20.07K -54.89K 76.42K -15.99K 15.99K 29.52K 10.11K -1.62K 14.3K 107.83K 75.17K 108.28K n/a
Shares Outstanding (Basic)
1.8M 1.8M 1.8M 1.77M 1.77M 1.77M 1.68M 1.45M 1.45M 1.45M 1.44M 1.43M 1.43M 1.43M 1.43M 1.43M 1.43M
Shares Outstanding (Diluted)
1.8M 1.8M 1.8M 1.77M 1.77M 1.77M 1.68M 1.45M 1.45M 1.45M 1.45M 1.44M 1.43M 1.43M 1.43M 1.43M 1.43M
EPS (Basic)
-0.04 -0.02 -0.07 0.01 -0.01 0.02 -0.16 -0.02 -0.00 -0.01 -0.01 -0.01 0.00 0.01 0.02 0.00 0.02
EPS (Diluted)
-0.04 -0.02 -0.07 0.01 -0.01 0.02 -0.16 -0.02 -0.00 -0.01 -0.01 -0.01 0.00 0.01 0.02 0.00 0.02
EBITDA
-618.42K -373.2K -1.29M 290.63K -49.44K 286.36K -2.5M -247.59K -25.76K -96.64K -39.38K -111.08K 61.34K 227.58K 399.46K 179.82K 357.16K
EBIT
n/a -416.22K -1.34M 259.17K -79.03K 256.71K -2.53M -272.2K -50.63K -122.69K -65.22K -137.96K 34.69K 201.06K 372.64K 139.99K 342.1K
Depreciation & Amortization
n/a 43.02K 49.08K 31.46K 29.59K 29.66K 29.29K 24.61K 24.87K 26.06K 25.83K 26.88K 26.65K 26.52K 26.82K 39.83K 15.06K